Of note, BRCA1 proficiency appeared to be disadvantageous to tumors in the absence of platinum exposure, as tumor relapses usually re-acquired BRCA1 LOH during therapy holidays, an effect we could not evaluate in this cohort31,63. The gene discussed is BRCA1; the disease is neoplasm.